Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial


Hamuryudan V., Mat C., Saip S., Ozyazgan Y., Siva A., Yurdakul S., ...Daha Fazla

ANNALS OF INTERNAL MEDICINE, cilt.128, sa.6, ss.443-451, 1998 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 128 Sayı: 6
  • Basım Tarihi: 1998
  • Doi Numarası: 10.7326/0003-4819-128-6-199803150-00004
  • Dergi Adı: ANNALS OF INTERNAL MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.443-451
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Recurrent oral and genital ulcers are the most frequent problem in the management of the Behcet syndrome. Uncontrolled experience suggests that thalidomide may help prevent recurrences of these ulcers.